CIK 0001819790 · Large accelerated filer
Tarsus Pharmaceuticals, Inc.
Sign in to watch- Ticker
- TARS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 814717861
- Phone
- (949) 409-9820
- Business address
- 15440 LAGUNA CANYON ROAD, IRVINE, CA, 92618
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,192,759
- in 6 filings, $5.2M under 10b5-1 plans
Net −$5,192,759. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-19 | Farrow Jeffrey S See Remarks | Sale | −1,254 | $47.40 | $59K | 23,617 |
| 2025-03-18 | Mottiwala Aziz Chief Commercial Officer | Sale | −3,643 | $46.29 | $169K | 71,979 |
| 2025-03-18 | Neervannan Seshadri Chief Operating Officer | Sale | −2,605 | $46.29 | $121K | 84,660 |
| 2025-03-18 | Wahl Bryan General Counsel | Sale | −3,341 | $46.29 | $155K | 58,057 |
| 2025-03-18 | Whitfield Dianne C. Chief Human Resources Officer | Sale | −2,315 | $46.29 | $107K | 50,751 |
| 2025-03-18 | Azamian Bobak R. President/CEO and Board Chair | Sale | −7,131 | $46.29 | $330K | 70,720 |
| 2025-03-18 | Farrow Jeffrey S See Remarks | Sale | −1,284 | $46.29 | $59K | 24,871 |
| 2025-03-17 | Farrow Jeffrey S See Remarks | Option exercise · Restricted Stock Units | −8,019 | 24,060 | ||
| 2025-03-15 | Farrow Jeffrey S See Remarks | Option exercise | +8,019 | 26,155 | ||
| 2025-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise | +51,395 | 77,851 | ||
| 2025-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −11,299 | 11,300 | ||
| 2025-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −16,975 | 33,950 | ||
| 2025-03-15 | Azamian Bobak R. President/CEO and Board Chair | Option exercise · Restricted Stock Units | −23,121 | 69,364 | ||
| 2025-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Option exercise | +18,885 | 53,066 | ||
| 2025-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Option exercise · Restricted Stock Units | −4,462 | 4,463 | ||
| 2025-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Option exercise · Restricted Stock Units | −7,248 | 14,497 | ||
| 2025-03-15 | Whitfield Dianne C. Chief Human Resources Officer | Option exercise · Restricted Stock Units | −7,175 | 21,527 | ||
| 2025-03-15 | Wahl Bryan General Counsel | Option exercise | +19,213 | 61,398 | ||
| 2025-03-15 | Wahl Bryan General Counsel | Option exercise · Restricted Stock Units | −4,790 | 4,790 | ||
| 2025-03-15 | Wahl Bryan General Counsel | Option exercise · Restricted Stock Units | −7,248 | 14,497 |
Page 11 of 13 · 257 trades